Nanoparticles for therapy of Alzheimer Disease

M. Masserini, M. Salmona, M. Gregori, G. Forloni, F. Re

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

NAD project (large cooperative; 19 partners, funded by the E.C., FP72007-2013, G.A. n° 212043) is aiming to the therapy and diagnosis, even combined, of Alzheimer Disease, by creating different multiple-functionalized nanoparticles, able to bind, detect and remove p-amyloid peptide (Aβ) from the brain and from the blood. The results obtained so far show the ability of liposomes functionalized to bind Abeta, to cross the blood-brain barrier either in vitro and in vivo and to reduce the Aβ burden from the brain of transgenic animal models of the disease, thus opening new vistas for the possible therapy of Alzheimer Disease in humans.

Original languageEnglish
Title of host publicationTechnical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013
Pages339-342
Number of pages4
Volume3
Publication statusPublished - 2013
EventNanotechnology 2013: Bio Sensors, Instruments, Medical, Environment and Energy - 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013 - Washington, DC, United States
Duration: May 12 2013May 16 2013

Other

OtherNanotechnology 2013: Bio Sensors, Instruments, Medical, Environment and Energy - 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013
CountryUnited States
CityWashington, DC
Period5/12/135/16/13

Fingerprint

Nanoparticles
Alzheimer Disease
Animal Diseases
Genetically Modified Animals
Aptitude
Brain
Blood-Brain Barrier
Amyloid
Liposomes
NAD
Animal Models
Therapeutics
poly(dG-dA)n.poly(dC-dT)n
In Vitro Techniques
peptide A

Keywords

  • Abeta
  • Alzheimer
  • Liposomes

ASJC Scopus subject areas

  • Biotechnology

Cite this

Masserini, M., Salmona, M., Gregori, M., Forloni, G., & Re, F. (2013). Nanoparticles for therapy of Alzheimer Disease. In Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013 (Vol. 3, pp. 339-342)

Nanoparticles for therapy of Alzheimer Disease. / Masserini, M.; Salmona, M.; Gregori, M.; Forloni, G.; Re, F.

Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013. Vol. 3 2013. p. 339-342.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Masserini, M, Salmona, M, Gregori, M, Forloni, G & Re, F 2013, Nanoparticles for therapy of Alzheimer Disease. in Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013. vol. 3, pp. 339-342, Nanotechnology 2013: Bio Sensors, Instruments, Medical, Environment and Energy - 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013, Washington, DC, United States, 5/12/13.
Masserini M, Salmona M, Gregori M, Forloni G, Re F. Nanoparticles for therapy of Alzheimer Disease. In Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013. Vol. 3. 2013. p. 339-342
Masserini, M. ; Salmona, M. ; Gregori, M. ; Forloni, G. ; Re, F. / Nanoparticles for therapy of Alzheimer Disease. Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013. Vol. 3 2013. pp. 339-342
@inproceedings{ee8c3d82ea0543b1a049f4c5e5089b9b,
title = "Nanoparticles for therapy of Alzheimer Disease",
abstract = "NAD project (large cooperative; 19 partners, funded by the E.C., FP72007-2013, G.A. n° 212043) is aiming to the therapy and diagnosis, even combined, of Alzheimer Disease, by creating different multiple-functionalized nanoparticles, able to bind, detect and remove p-amyloid peptide (Aβ) from the brain and from the blood. The results obtained so far show the ability of liposomes functionalized to bind Abeta, to cross the blood-brain barrier either in vitro and in vivo and to reduce the Aβ burden from the brain of transgenic animal models of the disease, thus opening new vistas for the possible therapy of Alzheimer Disease in humans.",
keywords = "Abeta, Alzheimer, Liposomes",
author = "M. Masserini and M. Salmona and M. Gregori and G. Forloni and F. Re",
year = "2013",
language = "English",
isbn = "9781482205862",
volume = "3",
pages = "339--342",
booktitle = "Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013",

}

TY - GEN

T1 - Nanoparticles for therapy of Alzheimer Disease

AU - Masserini, M.

AU - Salmona, M.

AU - Gregori, M.

AU - Forloni, G.

AU - Re, F.

PY - 2013

Y1 - 2013

N2 - NAD project (large cooperative; 19 partners, funded by the E.C., FP72007-2013, G.A. n° 212043) is aiming to the therapy and diagnosis, even combined, of Alzheimer Disease, by creating different multiple-functionalized nanoparticles, able to bind, detect and remove p-amyloid peptide (Aβ) from the brain and from the blood. The results obtained so far show the ability of liposomes functionalized to bind Abeta, to cross the blood-brain barrier either in vitro and in vivo and to reduce the Aβ burden from the brain of transgenic animal models of the disease, thus opening new vistas for the possible therapy of Alzheimer Disease in humans.

AB - NAD project (large cooperative; 19 partners, funded by the E.C., FP72007-2013, G.A. n° 212043) is aiming to the therapy and diagnosis, even combined, of Alzheimer Disease, by creating different multiple-functionalized nanoparticles, able to bind, detect and remove p-amyloid peptide (Aβ) from the brain and from the blood. The results obtained so far show the ability of liposomes functionalized to bind Abeta, to cross the blood-brain barrier either in vitro and in vivo and to reduce the Aβ burden from the brain of transgenic animal models of the disease, thus opening new vistas for the possible therapy of Alzheimer Disease in humans.

KW - Abeta

KW - Alzheimer

KW - Liposomes

UR - http://www.scopus.com/inward/record.url?scp=84881111404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881111404&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:84881111404

SN - 9781482205862

VL - 3

SP - 339

EP - 342

BT - Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013

ER -